{
    "2020-06-02": [
        [
            {
                "time": "",
                "original_text": "天坛生物(600161.SH)：董事会通过关于兰州血制永昌兰生单采血浆有限责任公司改造项目",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "董事会",
                        "兰州血制",
                        "永昌兰生",
                        "单采血浆",
                        "改造项目"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物(600161.SH)：董事会通过关于兰州血制产业化基地项目购置土地的议案",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "董事会",
                        "兰州血制",
                        "产业化基地",
                        "购置土地"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【中信建投医药|行业周报】如何看待下半年医药行情：继续拥抱高景气主线",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药",
                        "行业周报",
                        "下半年",
                        "高景气主线"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "粤开医药6月谈：医药大分化下的结构性行情必然性",
                "features": {
                    "keywords": [
                        "粤开医药",
                        "6月",
                        "医药",
                        "大分化",
                        "结构性行情"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}